Search hospitals > Missouri > Bolivar
Central Care Cancer Center - Bolivar
Claim this profileBolivar, Missouri 65613
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
Conducts research for Adenocarcinoma
226 reported clinical trials
3 medical researchers
Summary
Central Care Cancer Center - Bolivar is a medical facility located in Bolivar, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Adenocarcinoma and other specialties. Central Care Cancer Center - Bolivar is involved with conducting 226 clinical trials across 439 conditions. There are 3 research doctors associated with this hospital, such as Jay W Carlson, Leonid Shunyakov, M.D., and Rakesh Gaur.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Jay W CarlsonMercy Hospital Saint Louis4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
201 reported clinical trials
281 drugs studied
Leonid Shunyakov, M.D.Central Care Cancer Center2 years of reported clinical research
Studies Tumors
Studies Breast Cancer
7 reported clinical trials
17 drugs studied
Rakesh GaurResearch Medical Center5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
7 reported clinical trials
22 drugs studied
Clinical Trials running at Central Care Cancer Center - Bolivar
Breast Cancer
Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Carcinoma
Melanoma
Gastric Cancer
Tumors
Renal Cell Carcinoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Central Care Cancer Center - Bolivar?
Central Care Cancer Center - Bolivar is a medical facility located in Bolivar, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Adenocarcinoma and other specialties. Central Care Cancer Center - Bolivar is involved with conducting 226 clinical trials across 439 conditions. There are 3 research doctors associated with this hospital, such as Jay W Carlson, Leonid Shunyakov, M.D., and Rakesh Gaur.